Company Filing History:
1 out of 10 
1 out of 375 Years Active: 2004-2008
Title: Innovations in Oncology: The Contributions of Katsuyuki Hamada
Introduction: Katsuyuki Hamada, a notable inventor based in Matsuyama, Japan, has significantly contributed to the field of oncology through his innovative research and patented technologies. With a total of two patents to his name, Hamada's work focuses on advancing gene therapy techniques for cancer treatment.
Latest Patents: Hamada's latest inventions include a patent for a tumor-specific promoter and its application. This innovation involves a promoter domain of 1816 bp or 441 bp located upstream of exon 1B of the IAI.3B gene, which exhibits high promoter activity specifically in ovarian cancer cells. Furthermore, an adenovirus that incorporates this promoter domain in the E1 domain has demonstrated a notable efficacy in inhibiting cell proliferation in ovarian cancer cells, marking a promising advancement in gene therapy for this type of cancer. Additionally, Hamada has secured a patent related to gene expression base sequences for therapeutic use and drugs intended for gene therapy, further underscoring his dedication to improving treatment options for cancer patients.
Career Highlights: Over his career, Katsuyuki Hamada has worked with esteemed organizations such as the New Industry Research Organization and Hisamitsu Pharmaceutical Company, Inc. His role in these companies has paved the way for groundbreaking research in the field of cancer therapeutics, significantly impacting the landscape of medical science.
Collaborations: Hamada has collaborated with various professionals, including Kazuhiro Yuda and Katsuhiko Akiyama. These partnerships have fostered an environment of innovation and have been instrumental in the development of his patentable inventions.
Conclusion: Katsuyuki Hamada's work exemplifies the vital intersection of innovation and healthcare. With his contributions to gene therapy and cancer treatment, he continues to pave the way for new strategies in the fight against ovarian cancer and beyond. His patents not only reflect his ingenuity but also his commitment to enhancing the efficacy of cancer therapies through scientific advancements.